Related Experiment Video
Updated: Jul 8, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Light activated compounds as antimicrobial agents - patently obvious?
1Dean's Office, Faculty of Science, University of Central Lancashire, Preston, PR1 2HE, UK. daphoenix@uclan.ac.uk
Abstract:
Microbial pathogens with resistance to conventional drugs are a problem of global proportions and may be viral such as HIV, bacterial as in the case of MRSA or eukaryotic as seen with the malarial parasite Plasmodium falciparum. In response, photodynamic antimicrobial chemotherapy (PACT) has been developed, which is the delivery of a non-toxic photosensitiser (PS) to the site of a microbial infection. When taken up by the pathogen, illumination of the PS by light at an appropriate wavelength can lead to inactivation of the pathogen through the production of highly reactive free radical species, which induce oxidative damage to lipid, proteins and DNA / RNA, and / or adduct formation between the PS and these microbial biomolecules. Here the photochemical and photophysical steps underlying PS antimicrobial action along with the desirable electronic and physiochemical properties of PS are briefly reviewed. The therapeutic uses of PS are then illustrated with reference to a number that have featured in recent patents, including: The induction of endogenous PS by aminolevulinic acid; phenothiazinium based PS, which are the most studied of PACT agents, psoralens and organorhodium complexes.
Insights
Photodynamic antimicrobial chemotherapy (PACT) uses photosensitizers (PS) to inactivate drug-resistant microbes like HIV and MRSA. Light activates PS, generating reactive species that damage pathogens, offering a novel therapeutic approach.
Area of Science:
- Biochemistry
- Microbiology
- Photochemistry
Background:
- Drug-resistant microbial pathogens (viral, bacterial, eukaryotic) pose a global health threat.
- Photodynamic antimicrobial chemotherapy (PACT) offers a novel therapeutic strategy.
- PACT involves photosensitizers (PS) that target microbial infections.
Purpose of the Study:
- To review the photochemical and photophysical mechanisms of PACT.
- To outline desirable properties for photosensitizer (PS) development.
- To illustrate therapeutic applications of PS in recent patents.
Main Methods:
- Review of photochemical and photophysical principles of PACT.
- Analysis of electronic and physicochemical properties of photosensitizers.
- Examination of patented therapeutic uses of specific photosensitizers.
Main Results:
- PACT efficacy relies on PS activation by light, producing reactive oxygen species.
- Reactive species induce oxidative damage to microbial biomolecules (lipids, proteins, nucleic acids).
- Photosensitizer-biomolecule adducts also contribute to pathogen inactivation.
Conclusions:
- PACT is a promising approach to combatting drug-resistant microbial infections.
- Understanding PS properties is crucial for developing effective PACT agents.
- Recent patents highlight diverse PS applications, including endogenous PS induction and specific chemical classes.
Related Concept Videos
Chemical Agents for Microbial Control
Antimicrobial Effectiveness
Photoluminescence: Applications
Biological Methods for Microbial Control
Hand hygiene
Hand washing...

